Genome editing of human primary keratinocytes by CRISPR/Cas9 reveals an essential role of the NLRP1 inflammasome in UVB sensing by Fenini, Gabriele et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Genome editing of human primary keratinocytes by CRISPR/Cas9 reveals
an essential role of the NLRP1 inflammasome in UVB sensing
Fenini, Gabriele ; Grossi, Serena ; Contassot, Emmanuel ; Biedermann, Thomas ; Reichmann, Ernst ;
French, Lars E ; Beer, Hans-Dietmar
Abstract: By forming a protective barrier, epidermal keratinocytes represent the first line of defense
against environmental insults. UVB radiation of the sun is a major challenge for the skin and can
induce inflammation, aging and eventually skin cancer. UVB induces an immune response in human
keratinocytes resulting in activation and secretion of the pro-inflammatory cytokines proIL-1￿ and -18.
This is mediated by assembly of protein complexes, termed inflammasomes. However, the mechanisms
underlying sensing of UVB by keratinocytes, and particularly the types of inflammasomes required for
cytokine secretion, are a matter of debate. To address these questions, we established a protocol that
allows the generation of CRISPR/Cas9-targeted human primary keratinocytes. Our experiments revealed
an essential role of the NLRP1 rather than the NLRP3 inflammasome in UVB sensing and subsequent
IL-1￿ and -18 secretion by keratinocytes. Moreover, NLRP1 but not NLRP3 was required for inflamma-
some activation in response to nigericin, a potassium ionophore and well-established NLRP3 activator in
immune cells. Since the CRISPR/Cas9-targeted cells retained their full differentiation capacity, genome
editing of human primary keratinocytes might be useful for numerous research and medical applications.
DOI: https://doi.org/10.1016/j.jid.2018.07.016
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-153056
Journal Article
Accepted Version
Originally published at:
Fenini, Gabriele; Grossi, Serena; Contassot, Emmanuel; Biedermann, Thomas; Reichmann, Ernst; French,
Lars E; Beer, Hans-Dietmar (2018). Genome editing of human primary keratinocytes by CRISPR/Cas9
reveals an essential role of the NLRP1 inflammasome in UVB sensing. Journal of Investigative Derma-
tology, 138(12):2644-2652.
DOI: https://doi.org/10.1016/j.jid.2018.07.016
Accepted Manuscript
Genome editing of human primary keratinocytes by CRISPR/Cas9 reveals an
essential role of the NLRP1 inflammasome in UVB sensing
Gabriele Fenini, Serena Grossi, Emmanuel Contassot, Thomas Biedermann, Ernst
Reichmann, Lars E. French, Hans-Dietmar Beer
PII: S0022-202X(18)32462-X
DOI: 10.1016/j.jid.2018.07.016
Reference: JID 1534
To appear in: The Journal of Investigative Dermatology
Received Date: 27 March 2018
Revised Date: 21 June 2018
Accepted Date: 6 July 2018
Please cite this article as: Fenini G, Grossi S, Contassot E, Biedermann T, Reichmann E, French LE,
Beer H-D, Genome editing of human primary keratinocytes by CRISPR/Cas9 reveals an essential role
of the NLRP1 inflammasome in UVB sensing, The Journal of Investigative Dermatology (2018), doi:
10.1016/j.jid.2018.07.016.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Genome editing of human primary keratinocytes by CRISPR/Cas9 reveals 
an essential role of the NLRP1 inflammasome in UVB sensing 
 
Gabriele Fenini1*, Serena Grossi1*, Emmanuel Contassot1,3, Thomas Biedermann2, Ernst 
Reichmann2, Lars E. French1,3, Hans-Dietmar Beer1,3‡ 
 
 
1
 Department of Dermatology, University Hospital Zurich, Switzerland 
2 Tissue Biology Research Unit, University Children’s Hospital Zurich, Switzerland 
3
 Faculty of Medicine, University of Zurich, Zurich, Switzerland 
 
* These authors contributed equally 
 
Keywords: keratinocytes, UVB, inflammasome, inflammation, NLRP1, CRISPR/Cas9 
 
Short title: Ablation of NLRP1 in human keratinocytes 
 
 
‡ Correspondence and requests for materials should be addressed to HDB (email: 
Hans-Dietmar.Beer@usz.ch; phone: +41 44 255 39 73; Gloriastrasse 31, CH- 8091 Zürich) 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
ABSTRACT 
By forming a protective barrier, epidermal keratinocytes represent the first line of defense 
against environmental insults. UVB radiation of the sun is a major challenge for the skin and 
can induce inflammation, aging and eventually skin cancer. UVB induces an immune 
response in human keratinocytes resulting in activation and secretion of the pro-inflammatory 
cytokines proIL-1β and -18. This is mediated by assembly of protein complexes, termed 
inflammasomes. However, the mechanisms underlying sensing of UVB by keratinocytes, and 
particularly the types of inflammasomes required for cytokine secretion, are a matter of 
debate. To address these questions, we established a protocol that allows the generation of 
CRISPR/Cas9-targeted human primary keratinocytes. Our experiments revealed an essential 
role of the NLRP1 rather than the NLRP3 inflammasome in UVB sensing and subsequent IL-
1β and -18 secretion by keratinocytes. Moreover, NLRP1 but not NLRP3 was required for 
inflammasome activation in response to nigericin, a potassium ionophore and well-established 
NLRP3 activator in immune cells. Since the CRISPR/Cas9-targeted cells retained their full 
differentiation capacity, genome editing of human primary keratinocytes might be useful for 
numerous research and medical applications. 
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INTRODUCTION 
Immune cells are able to detect many different stress factors, such as pathogens or 
endogenous molecules released upon injury. In response to these insults, they initiate an 
inflammatory response, which helps to eliminate the stressors and to restore a new 
homeostatic state (Medzhitov, 2008). Inflammasomes represent multimeric protein 
complexes, which are critically involved in these processes (Strowig et al., 2012). They 
consist of a sensor protein, including NOD-like receptor family pyrin domain containing 1 
(NLRP1), NLRP3 or absent in melanoma 2 (AIM2), the adaptor protein apoptosis-associated 
speck-like protein containing CARD (ASC) and the protease caspase-1. Assembly of 
inflammasomes induces activation of caspase-1, which in turn cleaves and thereby activates 
the pro-inflammatory cytokines proIL-1β and -18 (Place and Kanneganti, 2017, Strowig et al., 
2012). Secretion of these cytokines induces an inflammatory response, which is supported by 
a lytic type of cell death termed pyroptosis. The latter is induced upon cleavage of gasdermin 
D by inflammatory caspases, as the amino terminal fragment of gasdermin D forms pores in 
the plasma membrane upon oligomerization (Kayagaki et al., 2015, Liu et al., 2016, Shi et al., 
2015). Inflammasomes are required for immunity, but play also a central role in 
inflammation, underlying many common (auto)inflammatory diseases (Fenini et al., 2017a, 
Strowig et al., 2012). 
In immune cells, expression of proIL-1β, NLRP3 or AIM2 must be induced before 
inflammasome activation, for example by Toll-like receptor (TLR) stimulation (Latz et al., 
2013). In contrast, human primary keratinocytes (hereafter HPKs) secrete IL-1β and -18 
without priming upon UVB irradiation (Feldmeyer et al., 2007, Strittmatter et al., 2016b). 
Several stress factors, including UVB radiation (Feldmeyer et al., 2007, Hasegawa et al., 
2016), cytoplasmic double-stranded DNA (Dombrowski et al., 2011), nanoparticles (Yazdi et 
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al., 2010), or viral infection (Reinholz et al., 2013, Strittmatter et al., 2016b), are described to 
induce inflammasome activation in HPKs. 
Although it has been reported that HPKs do not express NLRP3 and that NLRP1 represents 
the important inflammasome sensor in these cells (Zhong et al., 2016), several groups 
suggested a role of the NLRP3 or AIM2 inflammasome in human keratinocytes (Dai et al., 
2011, Dai et al., 2017, Dombrowski et al., 2011, Feldmeyer et al., 2007, Strittmatter et al., 
2016b). In these studies, expression of inflammasome components was targeted by RNA 
interference. However, it is well known that RNA molecules can modulate the innate immune 
system, for example via the TLR pathway and, therefore, can possibly influence 
inflammasome expression and activity (Agrawal and Kandimalla, 2004, Robbins et al., 2009). 
Consequently, the role of specific inflammasome sensors in human primary keratinocytes 
should be addressed by approaches different from siRNA- or shRNA-mediated knockdown. 
Interestingly, activating mutations in the gene encoding NLRP1 cause skin inflammation 
induced by hyperactivation of the inflammasome in keratinocytes and thereby increase the 
risk of developing skin cancer, demonstrating that inflammasome activation in human 
keratinocytes is also highly relevant in vivo (Zhong et al., 2016). In contrast, murine 
keratinocytes do neither express detectable amounts of proIL-1β protein nor assemble 
functional inflammasomes (Sand et al., 2018). 
Isolation and propagation of keratinocytes, including epidermal stem cells, is a well-
established method, which requires co-culture in the presence of mitotically-inactivated 
murine fibroblasts as “feeder” cells (Rheinwald and Green, 1975). Genetic manipulation of 
HPKs represents a useful tool for targeted gene therapy of diseases affecting keratinocytes. 
Recently, it has been demonstrated that epidermal stem cells from a patient suffering from 
junctional epidermolysis bullosa, a devastating disease caused by a defective LAMB3 gene, 
can be “corrected” upon transduction with a retroviral vector encoding the wild-type protein 
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(Mavilio et al., 2006). Furthermore, through production of autologous epidermal sheets with 
the help of feeder cells, even the entire epidermis of a seven-year-old boy could be replaced 
by wild-type LAMB3-overexpressing keratinocytes (Hirsch et al., 2017). However, genome 
editing via the CRISPR/Cas9 approach would allow a more specific genetic modification of 
keratinocytes and, in principle, gene therapy for other genetic diseases affecting keratinocytes 
of the epidermis (Doudna and Charpentier, 2014, Zhang et al., 2014). In addition, direct 
targeting of human primary keratinocytes by CRISPR/Cas9 would represent a very useful tool 
for answering many scientific, medical and pharmacological questions in dermatological 
research. 
Here, we developed and optimized a protocol for the generation of knockout HPKs with the 
CRISPR/Cas9 technology. Genetic modification and selection of the targeted keratinocytes 
was achieved by co-culture with antibiotic-resistant and proliferation-incompetent murine 
fibroblasts. CRISPR/Cas9-targeted keratinocytes retained the ability of differentiation and 
were able to form three-dimensional skin equivalents. The comparison of keratinocytes 
lacking either NLRP1, NLRP3 or ASC expression revealed an essential role of the NLRP1 
inflammasome in UVB- and nigericin-induced IL-1β and -18 secretion. 
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RESULTS 
Establishment of a protocol for stable genetic modification of keratinocytes 
Isolation of human primary keratinocytes (HPKs) from skin biopsies (Rasmussen et al., 2013, 
Rheinwald and Green, 1975) or plucked hair (Aasen and Izpisua Belmonte, 2010) is well 
established and the culture of HPKs represents a physiologically relevant model in 
dermatologic research (Strittmatter et al., 2016a). Isolation and propagation of HPKs on 
coated or non-coated surfaces with special low-Ca2+ and serum-free media is simple and 
suppresses growth of other skin-derived cells, such as fibroblasts, Langerhans cells or 
melanocytes (Zare et al., 2014). However, under these culturing conditions, HPKs are prone 
to terminal differentiation and stop proliferation after few passages. In contrast, cultivation of 
HPKs in the presence of proliferation-incompetent 3T3 fibroblasts strongly increases their 
lifetime. In particular, the clone 3T3-J2 has been used for propagation of keratinocytes. 
However, these co-cultures are more elaborate than mono-cultures (Rasmussen et al., 2013, 
Strittmatter et al., 2016a). 
Genetic manipulation of HPKs is a useful tool for dermatological research and method of 
choice is lentiviral transduction (Nanba et al., 2013), since transfection of plasmid DNA is 
highly toxic and can cause inflammasome activation (Strittmatter et al., 2016b). 
We developed and optimized a protocol for the stable genetic modification of HPKs (Figure 
1) based on their lentiviral transduction and co-culture with 3T3-J2 feeder cells. After 
separation of epidermis and dermis from a skin biopsy, keratinocytes were isolated from the 
epidermal layer upon enzymatic digestion with trypsin and seeded onto mitotically-
inactivated (proliferation-incompetent) feeder cells in the presence of the Rho-associated, 
coiled-coil containing protein kinase (ROCK) inhibitor Y-27632 (day 1). Culture in the 
presence of this inhibitor enhances the survival and proliferation of epidermal stem cells 
(Nanba et al., 2013, Strudwick et al., 2015) and is therefore maintained until the first 
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trypsinization. After medium change (day 2), HPKs were transduced with lentiviruses at day 
3 in the presence of polybrene (hexadimethrine bromide). Two days and a medium change 
later, the remaining feeder cells were gently removed with a diluted trypsin/EDTA solution, 
HPKs were detached by standard trypsinization and seeded on a new layer of puromycin-
resistant and mitotically-inactivated feeder cells (day 5) in the presence of the ROCK 
inhibitor. The optimal density for trypsinization of HPKs was 50-60%, but not higher than 
70%, as confluent cells irreversibly lose their proliferative capacity (Supplementary Figure 
S1). Transduction of HPKs with a lentiviral construct encoding a single guide (sg) RNA 
targeting the ASC gene and encoding Cas9 resulted in almost complete ablation of ASC 
expression by selecting the transduced HPKs with high concentrations of puromycin (5 
µg/ml) for one week (Figure 2a and b). Prolonged selection of HPKs with puromycin rather 
than high concentrations for few days negatively influenced their long-term survival (results 
not shown). 
In brief, we successfully established a protocol for the efficient stable genetic modification of 
HPKs. This was achieved by lentiviral transduction and selection of transduced cells with 
antibiotics in co-culture with antibiotics-resistant feeder cells. This protocol allows the 
generation of CRISPR/Cas9-mediated knockout HPKs but also of HPKs which overexpress 
proteins in an inducible or constitutive manner (not shown). 
 
Characterization of knockout HPKs 
Using the above-described protocol, we targeted expression of genes encoding the 
inflammasome proteins caspase-1 or ASC in HPKs. Western blots of the cell lysates of 
targeted cells revealed a dramatic reduction in caspase-1 or ASC protein expression (Figure 
2c). ASC and caspase-1 expression are required for UVB-induced inflammasome activation 
in HPKs (Feldmeyer et al., 2007). In order to assess, whether the generated CRISPR/Cas9-
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targeted HPKs are able to form a functional inflammasome, we irradiated these cells with 
UVB and analyzed IL-1β secretion as a readout for inflammasome activation. As expected, in 
ASC and caspase-1 sgRNA CRISPR/Cas9-targeted HPKs IL-1β secretion was strongly 
reduced compared to control cells as revealed by Western blot (Figure 2c) and ELISA (Figure 
2d). This confirms earlier results obtained by siRNA-mediated knockdown experiments 
(Feldmeyer et al., 2007). Very importantly, control CRISPR/Cas9-targeted HPKs, which were 
transduced with a non-targeting sgRNA, secreted similar amounts of IL-1β as non-transduced 
wild-type cells. These results demonstrate that lentiviral transduction and selection of 
transduced HPKs by puromycin do not affect their ability to form active inflammasomes. 
Therefore, CRISPR/Cas9 targeting and manipulation of HPKs is a useful tool for 
investigating inflammasome activation in these cells. 
Furthermore, we addressed the question, whether the CRISPR/Cas9-targeted HPKs retain full 
differentiation capacity. Ablation of ASC expression in epidermal keratinocytes of mice does 
not cause a spontaneous phenotype, demonstrating that it is not required for differentiation of 
murine keratinocytes (Drexler et al., 2012). Likewise, cultivation in the absence of EGF 
induced differentiation of control, caspase-1 and ASC sgRNA CRISPR/Cas9-targeted HPKs 
in a similar manner and, most importantly, comparable to wild-type keratinocytes (Figure 2e). 
Indeed, wild-type, control, caspase-1 and ASC sgRNA CRISPR/Cas9-targetd HPKs induced 
expression of early differentiation markers, such as keratin 1 and keratin 10, but also of 
filaggrin and involucrin, which are expressed in the stratum granulosum and stratum corneum, 
after three days in culture without EGF. When cultivated on collagen gels containing human 
primary fibroblasts, HPKs form a three-dimensional structure, resembling characteristic 
features of the epidermis in vivo (Pontiggia et al., 2009). In order to test, whether our protocol 
is compatible with stratification and three-dimensional differentiation of HPKs in skin 
equivalents, we seeded wild-type and ASC sgRNA CRISPR/Cas9-targeted HPKs on top of a 
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collagen-based dermal equivalent. After two weeks in culture, both preparations resulted in 
skin equivalents with a stratified epidermis-like structure (Supplementary Figure S2). These 
experiments demonstrate that sgRNA CRISPR/Cas9-targeted HPKs, are able to differentiate 
in two- and three-dimensional culture in vitro and, therefore, most likely, also in vivo. 
 
UVB activates the NLRP1 rather than the NLRP3 inflammasome in HPKs 
Recently, it has been suggested that NLRP1 is the predominant inflammasome sensor in 
human keratinocytes (Zhong et al., 2016). In contrast, other publications demonstrated also 
important roles of the NLRP3 and AIM2 inflammasomes in HPKs (Dombrowski et al., 2011, 
Feldmeyer et al., 2007, Hasegawa et al., 2016, Reinholz et al., 2013). An siRNA approach 
suggested that both NLRP1 and NLRP3 contribute to UVB-induced IL-1β secretion in HPKs 
(Feldmeyer et al., 2007). On the other hand, pharmacological inhibition of the NLRP3 
inflammasome had no effect on IL-1β release by HPKs (Fenini et al., 2017b). To address this 
inconsistency, we generated NLRP1 and NLRP3 sgRNA CRISPR/Cas9-targeted HPKs, using 
two different sgRNAs, respectively; ASC sgRNA CRISPR/Cas9-targeted cells served as 
control. Gene targeting was assessed 5 days after transduction by genomic cleavage detection 
assays (Supplementary Figure S3). Protein downregulation was confirmed by Western blots 
(Figure 3a). Expression of NLRP3 can be detected only upon priming with IFNγ (Strittmatter 
et al., 2016b). Under this condition, NLRP3 protein expression was absent in NLRP3 sgRNA 
CRISPR/Cas9-targeted cells. Western blots revealed that expression of caspase-1, ASC, 
proIL-1β and proIL-18 was not affected by ablation of NLRP1 and NLRP3 (Figure 3a). When 
exposed to UVB, ASC and NLRP1 but not NLRP3 CRISPR/Cas9-targeted HPKs showed a 
strongly reduced inflammasome activation, even after priming with IFNγ, as reflected by the 
diminished IL-1β and -18 secretion (Figure 3b-d) and LDH release (Figure 3e). Nigericin is a 
well-established stimulus for NLRP3 inflammasome activation in immune cells (Mariathasan 
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et al., 2006). Interestingly, NLRP3 depletion in HPKs did not influence IL-1β release upon 
treatment with nigericin. In contrast, ablation of NLRP1 expression impaired IL-1β and -18 
secretion in a similar manner as targeting of ASC expression (Figure 3b-d). As expected, 
targeting of ASC, but neither of NLRP1 nor NLRP3, impaired cytokines secretion in response 
to poly(dA:dT), an AIM2 inflammasome activator (Supplementary Figure S5). These 
experiments suggest that NLRP1 rather than NLRP3 is the key inflammasome sensor in 
HPKs. 
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DISCUSSION 
By inducing inflammation, inflammasomes play a fundamental role in immunity as well as in 
many different common (auto)inflammatory diseases, ranging from diabetes to atherosclerosis 
(Larsen et al., 2007, Ridker et al., 2017, Strowig et al., 2012). Upon the detection of a broad 
variety of danger signals, they mount an immune response by activation of caspase-1 and in 
turn by release of mature IL-1β and -18. Inflammasome components are mainly expressed by 
immune cells upon priming, like TLR signaling, which induces expression of proIL-1β and 
other inflammasome components, such as NLRP3 and AIM2 (Place and Kanneganti, 2017, 
Strowig et al., 2012). Furthermore, IL-1β secretion can also be induced in HPKs by UVB 
irradiation, which does not require a specific priming signal (Faustin and Reed, 2008, 
Feldmeyer et al., 2007). UVB is a major threat for epidermal keratinocytes and induces 
inflammation, skin aging and eventually skin cancer. How HPKs sense UVB radiation is 
poorly understood, but studies based on si- or shRNA-mediated knockdown experiments 
suggested a role of both the NLRP1 and NLRP3 inflammasome (Feldmeyer et al., 2007, 
Hasegawa et al., 2016). 
Mice are a frequently used model in biological and medical research, including skin studies. 
However, in contrast to HPKs, previous studies suggest that murine keratinocyte do neither 
express proIL-1β nor form active inflammasomes (Sand et al., 2018). In addition, caspase-1 is 
a regulator of UVB-induced apoptosis in HPKs but is dispensable for this process in murine 
keratinocytes and in the epidermis of these animals (Sollberger et al., 2015). Therefore, there 
are important differences concerning the role of inflammasomes in human versus murine 
keratinocytes and skin. Recently, it was reported that activating mutations in the NLRP1 gene 
cause skin inflammation in humans, which is mediated by inflammasome activation in 
keratinocytes (Zhong et al., 2016). Since expression of NLRP3 in HPKs and in human skin 
could not be detected, it was concluded that NLRP1 is the most important inflammasome 
sensor in human keratinocytes (Zhong et al., 2016), in contrast to several other reports based 
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on si- and shRNA experiments (Dombrowski et al., 2011, Feldmeyer et al., 2007, Hasegawa 
et al., 2016, Reinholz et al., 2013, Strittmatter et al., 2016b, Watanabe et al., 2007, Yazdi et 
al., 2010). As it is well known that siRNA and shRNA can induce and modulate immune 
responses relevant for the inflammasome pathway (Agrawal and Kandimalla, 2004, Robbins 
et al., 2009), we targeted ASC, caspase-1, NLRP1 and NLRP3 expression by sgRNA and 
CRISPR/Cas9. In contrast to siRNA and shRNA approaches, genome editing of HPKs with 
CRISPR/Cas9 has much less severe effects on immune pathways, including inflammasomes. 
Most importantly, in contrast to NLRP3 sgRNA CRISPR/Cas9-targetd HPKs, those with 
ablated ASC or NLRP1 expression secreted drastically reduced levels of IL-1β upon UVB 
irradiation as well as upon treatment with nigericin compared to the corresponding control 
cells. This demonstrates that NLRP1 rather than NLRP3 is the main inflammasome sensor of 
HPKs, as also recently suggested (Fenini et al., 2017b). The importance of NLRP1 in human 
skin is also supported by other reports demonstrating a susceptibility to skin inflammation and 
autoimmunity, such as vitiligo and psoriasis, caused by variations in NLRP1 (Ekman et al., 
2014, Jin et al., 2007a, Jin et al., 2007b, Levandowski et al., 2013). It has been suggested that 
particularly mouse NLRP1 can directly activate caspase-1 by CARD-CARD interactions 
independently of ASC expression, although the presence of ASC further supports activation 
of the protease (Van Opdenbosch et al., 2014, Yu et al., 2018). In contrast, ASC 
CRISPR/Cas9-targeted HPKs did not secrete IL-1β upon UVB radiation (Figure 2c-d and 
Figure 3a-e), demonstrating that in HPKs ASC expression is needed for NLRP1 
inflammasome activation. 
Notably, we established a protocol for sgRNA CRISPR/Cas9-targeting of HPKs. HPKs 
represent an established model for many different research and medical applications. They are 
frequently used in monoculture or in conjunction with dermal fibroblasts in more 
sophisticated three-dimensional models, where keratinocytes form a stratified epithelium, 
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resembling human skin (Pontiggia et al., 2009). However, HPKs in monoculture undergo 
differentiation after few passages, thus limiting their applications. The use of fibroblasts as 
feeder cells extends the lifespan of HPKs and is the method of choice, when large amounts of 
HPKs are required (Rasmussen et al., 2013, Rheinwald and Green, 1975). 
Recently, CRISPR/Cas9 technology was used to correct a mutation in the COL7A1 gene 
causing dominant (Shinkuma et al., 2016) and recessive (Webber et al., 2016) dystrophic 
epidermolysis bullosa in vitro. Patient-derived fibroblasts or induced pluripotent stem cells 
(iPSCs) were targeted by CRISPR/Cas9, differentiated into keratinocytes and expanded on 
feeder cells. 
Our approach, instead, targets directly HPKs, requires less manipulation of the cells and 
allows their selection. However, for the future, improvements of our protocol, particularly for 
gene therapeutic applications, are necessary. HPKs should be expanded after genetic 
modification by CRISPR/Cas9 from single cells, allowing the selection of true knockouts and 
even knockins and their characterization by sequencing. Lentiviral or retroviral integration 
can disrupt genetic information resulting in aberrant transcripts and possibly leading to cancer 
development (Hirsch et al., 2017, Moiani et al., 2012, Qian et al., 2017). This can be avoided 
using other currently available approaches, such as transfection of the recombinant Cas9 
protein with the sgRNA of interest. 
Here, we demonstrate successful sgRNA CRISPR/Cas9-targeting of HPKs. The modification 
of HPKs by CRISPR/Cas9 has the potential to result in excellent research models, for 
example in combination with human skin equivalents. This is strongly required due to 
obvious limitations of animal experimentation. In addition, several applications in human 
patients are conceivable, which go far beyond the treatment of epidermolysis bullosa. 
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MATERIALS AND METHODS 
Cell culture 
HEK 293T cells (ATCC CRL-3216, Manassas, VA), 3T3-J2 feeder cells (ATCC CRL-1658) 
and 3T3-J2 puromycin-resistant feeder cells were cultured in DMEM (Thermo Fisher 
Sientific, Waltham, MA) supplemented with 10% FBS (PAN-Biotech, Aidenbach, DE) and 
1% antibiotic/antimycotic (A/A, Thermo Fisher Scientific). Cells were harvested with 
trypsin/EDTA solution (0.05%/0.02% w/v) (Thermo Fisher Scientific). 
Co-cultures of HPKs and 3T3-J2 feeder cells were performed in Rheinwald and Green 
Medium (RGM; 3 parts DMEM, 1 part HAM’s F12 Nutrient Mixture (Thermo Fisher 
Scientific), 10% FBS, 1% A/A, 20 µg/ml adenine (Sigma-Aldrich, St. Louis, MA), 5 µg/ml 
apo-transferrin (Sigma-Aldrich), 2 nM 3,3’,5-triiodothyronin (Sigma-Aldrich), 200 ng/ml 
hydrochortisone (Sigma-Aldrich), 100 pg/ml choleratoxin (Sigma-Aldrich), 5 µg/ml insulin 
(Sigma-Aldrich), 10 ng/ml EGF (Sigma-Aldrich)). HPKs were trypsinized at an optimal 
density of 50-60%. Prior to trypsinization of HPKs, 3T3-J2 feeder cells were removed by 
short incubation with diluted trypsin/EDTA solution (0.005%/0.05% w/v in DPBS). HPKs 
were detached with trypsin/EDTA solution (0.05%/0.02% w/v) and seeded onto a new layer 
of mitotically-inactivated 3T3-J2 feeder cells in RGM supplemented with 10 µM ROCK1 
inhibitor (Y-27632 2HCl, Selleckchem, Houston, TX). After 24 hours the medium was 
changed to standard RGM and HPKs were maintained in co-culture with 3T3-J2 feeder cells 
until experiment. 
Mono-cultures of HPKs were grown in serum-free keratinocyte medium (KSFM, Thermo 
Fisher Scientific) supplemented with EGF and bovine pituitary extract (BPE). Cells were 
harvested as described above and cultured for at least 48 hours before experiment. 
All cells were incubated at 37 °C in 5% CO2 and 95% humidity.  
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Manipulation of cells 
3T3-J2 puromycin-resistant feeder cells were generated in order to allow selection of co-
cultured lentivirally-transduced HPKs. 3T3-J2 feeder cells were transduced with pLenti 
CMVtight Puro DEST (w768-1) (Addgene, #26430) and selected with 5 µg/ml puromycin 
(Sigma-Aldrich). 
In order to inhibit cell proliferation, 3T3-J2 and 3T3-J2 puromycin-resistant feeder cells were 
treated for 2 hours at 37 °C with 10 µg/ml mitomycin C (Santa Cruz Biotechnology, Dallas, 
TX) diluted in growth medium. Cells were washed three times with DPBS, trypsinized as 
described above and plated in growth medium at a density of 50%. 
 
Isolation of human primary keratinocytes from skin biopsies 
Skin biopsies were disinfected by a short incubation with 70% ethanol and washed in DPBS. 
Fat was removed, and the remaining tissue cut into small pieces. The skin pieces were 
incubated for 2 hours in DMEM containing 1% A/A and subsequently overnight in 4 U/ml 
dispase II (Roche, Rotkreuz, CH) in DPBS at 4 °C. Separation of dermis and epidermis was 
performed the next day, and the epidermis was incubated for 20 min at 37 °C in 
trypsin/EDTA solution (0.25%/0.02%). A single cell suspension of keratinocytes was 
obtained by pipetting the epidermis up and down in DMEM containing 25% FBS and 1% 
A/A and passing the cell suspension through a 100 µm nylon strainer (BD, Franklin Lakes, 
NJ). Cells were centrifuged (170 × g, 3 min, RT), resuspended and plated onto mitotically-
inactivated 3T3-J2 feeder cells (with a 5 to 1 ratio) in RGM without EGF supplemented with 
10 µM ROCK1 inhibitor. 
Skin biopsies were collected with informed written consent upon approval from Local Ethical 
Committees and were conducted according to the Declaration of Helsinki Principles. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
16 
 
 
 
Generation of CRISPR/Cas9-targeted human primary keratinocytes 
Single guide RNA (sgRNA) were designed using the Benchling platform 
(https://benchling.com) and single-stranded DNA oligonucleotides (Supplementary Table S1) 
purchased from Microsynth (Balgach, Switzerland) were cloned into the lentiCRISPRv2 
plasmid (Addgene, #52961) (Sanjana et al., 2014). Plasmids were co-transfected into HEK 
293T cells with the packaging vectors psPAX2 (Addgene, #12260) and pMD2.G (Addgene, 
#12259) and 48 hours later lentiviruses were harvested and concentrated by centrifugation 
(16000 × g, 4 hrs, 4 °C). HPKs co-cultured with 3T3-J2 feeder cells were transduced 2 days 
after isolation. Concentrated viruses were dissolved in RGM containing 10 µM ROCK1 
inhibitor and 2.5 µg/ml polybrene (hexadimethrine bromide) (Sigma). Medium was changed 
24 hours after transduction to RGM containing 10 µM ROCK1 inhibitor. HPKs were splitted 
4-5 days after isolation and seeded onto a fresh layer of mitotically-inactivated 3T3-J2 
puromycin-resistant feeder cells in RGM containing 10 µΜ Y-27632. After 24 hours medium 
was changed to RGM containing 5 µg/ml puromycin (Sigma). Selection was performed for 48 
hours. CRISPR/Cas9 targeting efficiency was assessed at the genomic level by processing the 
DNA with the Genomic Cleavege Detektion Kit (Thermo Fisher Sientific) or at the protein 
level by Western blot. 
 
Inflammasome activation in human primary keratinocytes 
For experiments, trypsinized HPKs were resuspended in KSFM supplemented with EGF and 
BPE and containing 10 µΜ Y-27632. After 24 hours medium was changed to KSFM 
(supplemented with EGF and BPE) and cells were grown until 70% density.  
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For priming, HPKs were exposed overnight to 20 ng/ml human interferon gamma (IFNγ) 
(Peprotech, Rocky Hill, NJ). 
Prior to inflammasome activation, medium was exchanged by fresh KSFM (supplemented 
with EGF and BPE). HPKs were either left untreated, irradiated with 86.4 mJ/cm2 UVB 
(UV802L, Waldmann, Villingen-Schwenninge, DE), stimulated with 5 µΜ nigericin 
(Selleckchem) or transfected with 2 µg/ml poly(dA:dT) (InvivoGen, San Diego, CA). 
 
In vitro differentiation of human primary keratinocytes 
HPKs were grown in KSFM (supplemented with EGF and BPE) and at 100% confluency, 
medium was replaced by keratinocyte basal medium (KBM)-chemically defined (CD) 
(Lonza, Basel, CH) supplemented with 0.1 mM ethanolamine and 0.1 mM 
phosphoethanolamine. 
 
Statistical analysis 
Statistical analysis was performed using unpaired Student’s t-test or one-way analysis of 
variance (ANOVA) followed by Dunnett’s multiple-comparison test using Prism software 
(GraphPad, La Jolla, CA). Differences were considered significant when: *P ≤ 0.05, **P ≤ 
0.01, ***P ≤ 0.001 and ****P ≤ 0.0001. 
 
CONFLICT OF INTEREST 
The authors state no conflict of interest. 
 
 
ACKNOWLEDGEMENTS 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
18 
 
We thank Dr. Annalisa Saltari for her advice and help in the isolation of HPKs. This work 
was supported by grants from the Wilhelm Sander-Stiftung, the Promedica Stiftung (Chur), 
the OPO-Stiftung and the Kurt und Senta Herrmann-Stiftung to HDB, the Swiss National 
Science Foundation (31003A-120400 and 310030-156384) and the Zurich University 
Research Priority Program “Translational Cancer Research” to LEF, and the Zurich 
University Forschungskredit Candoc to GF. GF and SG were members of the Life Science 
Zurich Graduate School. 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
19 
 
REFERENCES 
Aasen T, Izpisua Belmonte JC. Isolation and cultivation of human keratinocytes from skin or 
plucked hair for the generation of induced pluripotent stem cells. Nat Protoc 
2010;5(2):371-82. 
Agrawal S, Kandimalla ER. Role of Toll-like receptors in antisense and siRNA [corrected]. 
Nat Biotechnol 2004;22(12):1533-7. 
Dai X, Sayama K, Tohyama M, Shirakata Y, Hanakawa Y, Tokumaru S, et al. Mite allergen 
is a danger signal for the skin via activation of inflammasome in keratinocytes. J 
Allergy Clin Immunol 2011;127(3):806-14 e1-4. 
Dai X, Tohyama M, Murakami M, Sayama K. Epidermal keratinocytes sense dsRNA via the 
NLRP3 inflammasome, mediating interleukin (IL)-1beta and IL-18 release. Exp 
Dermatol 2017;26(10):904-11. 
Dombrowski Y, Peric M, Koglin S, Kammerbauer C, Goss C, Anz D, et al. Cytosolic DNA 
triggers inflammasome activation in keratinocytes in psoriatic lesions. Science 
translational medicine 2011;3(82):82ra38. 
Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with 
CRISPR-Cas9. Science 2014;346(6213):1258096. 
Drexler SK, Bonsignore L, Masin M, Tardivel A, Jackstadt R, Hermeking H, et al. Tissue-
specific opposing functions of the inflammasome adaptor ASC in the regulation of 
epithelial skin carcinogenesis. Proc Natl Acad Sci U S A 2012;109(45):18384-9. 
Ekman AK, Verma D, Fredrikson M, Bivik C, Enerback C. Genetic variations of NLRP1: 
susceptibility in psoriasis. Br J Dermatol 2014;171(6):1517-20. 
Faustin B, Reed JC. Sunburned skin activates inflammasomes. Trends Cell Biol 2008;18(1):4-
8. 
Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer HD. The inflammasome mediates 
UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 
2007;17(13):1140-5. 
Fenini G, Contassot E, French LE. Potential of IL-1, IL-18 and Inflammasome Inhibition for 
the Treatment of Inflammatory Skin Diseases. Front Pharmacol 2017a;8:278. 
Fenini G, Grossi S, Gehrke S, Beer HD, Satoh TR, Contassot E, et al. The p38 mitogen-
activated protein kinase critically regulates human keratinocyte inflammasome 
activation. J Invest Dermatol 2017b. 
Hasegawa T, Nakashima M, Suzuki Y. Nuclear DNA damage-triggered NLRP3 
inflammasome activation promotes UVB-induced inflammatory responses in human 
keratinocytes. Biochem Biophys Res Commun 2016;477(3):329-35. 
Hirsch T, Rothoeft T, Teig N, Bauer JW, Pellegrini G, De Rosa L, et al. Regeneration of the 
entire human epidermis using transgenic stem cells. Nature 2017;551(7680):327-32. 
Jin Y, Birlea SA, Fain PR, Spritz RA. Genetic variations in NALP1 are associated with 
generalized vitiligo in a Romanian population. J Invest Dermatol 2007a;127(11):2558-
62. 
Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, et al. NALP1 in 
vitiligo-associated multiple autoimmune disease. N Engl J Med 2007b;356(12):1216-
25. 
Kayagaki N, Stowe IB, Lee BL, O'Rourke K, Anderson K, Warming S, et al. Caspase-11 
cleaves gasdermin D for non-canonical inflammasome signalling. Nature 
2015;526(7575):666-71. 
Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, et al. Interleukin-1-
receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356(15):1517-26. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 
2013;13(6):397-411. 
Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, Jin Y, et al. NLRP1 
haplotypes associated with vitiligo and autoimmunity increase interleukin-1beta 
processing via the NLRP1 inflammasome. Proc Natl Acad Sci U S A 
2013;110(8):2952-6. 
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated 
gasdermin D causes pyroptosis by forming membrane pores. Nature 
2016;535(7610):153-8. 
Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, et al. 
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 
2006;440(7081):228-32. 
Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, Recchia A, et al. Correction of 
junctional epidermolysis bullosa by transplantation of genetically modified epidermal 
stem cells. Nat Med 2006;12(12):1397-402. 
Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454(7203):428-
35. 
Moiani A, Paleari Y, Sartori D, Mezzadra R, Miccio A, Cattoglio C, et al. Lentiviral vector 
integration in the human genome induces alternative splicing and generates aberrant 
transcripts. J Clin Invest 2012;122(5):1653-66. 
Nanba D, Matsushita N, Toki F, Higashiyama S. Efficient expansion of human keratinocyte 
stem/progenitor cells carrying a transgene with lentiviral vector. Stem Cell Res Ther 
2013;4(5):127. 
Place DE, Kanneganti TD. Recent advances in inflammasome biology. Curr Opin Immunol 
2017;50:32-8. 
Pontiggia L, Biedermann T, Meuli M, Widmer D, Bottcher-Haberzeth S, Schiestl C, et al. 
Markers to evaluate the quality and self-renewing potential of engineered human skin 
substitutes in vitro and after transplantation. J Invest Dermatol 2009;129(2):480-90. 
Qian W, Wang Y, Li RF, Zhou X, Liu J, Peng DZ. Prolonged Integration Site Selection of a 
Lentiviral Vector in the Genome of Human Keratinocytes. Med Sci Monit 
2017;23:1116-22. 
Rasmussen C, Thomas-Virnig C, Allen-Hoffmann BL. Classical human epidermal 
keratinocyte cell culture. Methods Mol Biol 2013;945:161-75. 
Reinholz M, Kawakami Y, Salzer S, Kreuter A, Dombrowski Y, Koglin S, et al. HPV16 
activates the AIM2 inflammasome in keratinocytes. Arch Dermatol Res 
2013;305(8):723-32. 
Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the 
formation of keratinizing colonies from single cells. Cell 1975;6(3):331-43. 
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. 
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J 
Med 2017;377(12):1119-31. 
Robbins M, Judge A, MacLachlan I. siRNA and innate immunity. Oligonucleotides 
2009;19(2):89-102. 
Sand J, Haertel E, Biedermann T, Contassot E, Reichmann E, French LE, et al. Expression of 
inflammasome proteins and inflammasome activation occurs in human, but not in 
murine keratinocytes. Cell Death Dis 2018;9(2):24. 
Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR 
screening. Nat Methods 2014;11(8):783-4. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21 
 
Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by 
inflammatory caspases determines pyroptotic cell death. Nature 2015;526(7575):660-
5. 
Shinkuma S, Guo Z, Christiano AM. Site-specific genome editing for correction of induced 
pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa. Proc 
Natl Acad Sci U S A 2016;113(20):5676-81. 
Sollberger G, Strittmatter GE, Grossi S, Garstkiewicz M, Auf dem Keller U, French LE, et al. 
Caspase-1 activity is required for UVB-induced apoptosis of human keratinocytes. J 
Invest Dermatol 2015;135(5):1395-404. 
Strittmatter GE, Garstkiewicz M, Sand J, Grossi S, Beer HD. Human Primary Keratinocytes 
as a Tool for the Analysis of Caspase-1-Dependent Unconventional Protein Secretion. 
Methods Mol Biol 2016a;1459:135-47. 
Strittmatter GE, Sand J, Sauter M, Seyffert M, Steigerwald R, Fraefel C, et al. IFN-gamma 
Primes Keratinocytes for HSV-1-Induced Inflammasome Activation. J Invest 
Dermatol 2016b;136(3):610-20. 
Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature 
2012;481(7381):278-86. 
Strudwick XL, Lang DL, Smith LE, Cowin AJ. Combination of low calcium with Y-27632 
rock inhibitor increases the proliferative capacity, expansion potential and lifespan of 
primary human keratinocytes while retaining their capacity to differentiate into 
stratified epidermis in a 3D skin model. PLoS One 2015;10(4):e0123651. 
Van Opdenbosch N, Gurung P, Vande Walle L, Fossoul A, Kanneganti TD, Lamkanfi M. 
Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 
autoproteolysis and speck formation. Nat Commun 2014;5:3209. 
Watanabe H, Gaide O, Petrilli V, Martinon F, Contassot E, Roques S, et al. Activation of the 
IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest 
Dermatol 2007;127(8):1956-63. 
Webber BR, Osborn MJ, McElroy AN, Twaroski K, Lonetree CL, DeFeo AP, et al. 
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis 
bullosa. NPJ Regen Med 2016;1. 
Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, et al. Nanoparticles 
activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause 
pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc Natl Acad 
Sci U S A 2010;107(45):19449-54. 
Yu CH, Moecking J, Geyer M, Masters SL. Mechanisms of NLRP1-Mediated 
Autoinflammatory Disease in Humans and Mice. J Mol Biol 2018;430(2):142-52. 
Zare S, Zarei MA, Ghadimi T, Fathi F, Jalili A, Hakhamaneshi MS. Isolation, cultivation and 
transfection of human keratinocytes. Cell Biol Int 2014;38(4):444-51. 
Zhang F, Wen Y, Guo X. CRISPR/Cas9 for genome editing: progress, implications and 
challenges. Hum Mol Genet 2014;23(R1):R40-6. 
Zhong FL, Mamai O, Sborgi L, Boussofara L, Hopkins R, Robinson K, et al. Germline 
NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via 
Inflammasome Activation. Cell 2016;167(1):187-202 e17. 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
22 
 
FIGURES 
Figure 1. Workflow for the generation of CRISPR/Cas9-targeted human primary 
keratinocytes (HPKs). 
(a) On day 0, mitotically-inactivated 3T3-J2 feeder cells are seeded at a density of 50%. (b) 
At day 1, freshly isolated HPKs were added (ratio HPKs: J2 5:1) and the medium was 
changed after 24 hrs (c). (d) Clones of 5-6 HPKs were transduced with lentiviral vectors 
encoding sgRNA and Cas9, and the medium was changed after 24 hrs (e). (f) HPKs were 
grown until they reached an optimal density of 50-60%; feeder cells were removed by a short 
incubation with diluted trypsin/EDTA solution (g) and keratinocytes were trypsinized and 
seeded on fresh mitotically-inactivated puromycin-resistant feeder cells. Selection started 24 
hrs after splitting. Scale bars, 100 µm; red dashed lines highlight keratinocyte clones. 
 
Figure 2. Generation and characterization of CRISPR/Cas9-targeted HPKs. 
(a) Western blot analysis and (b) quantification of ASC bands using lysate of HPKs 
transduced with a lentiviral vector targeting the ASC gene or a non-targeting sgRNA (control) 
and cultured under puromycin selection as indicated. (b) The intensities of ASC bands on 
Western blots were normalized to β-actin protein levels and are shown relative to the levels 
seen in control sgRNA-targeted CRISPR/Cas9 HPKs. sgRNA targeted genes and antibodies 
used for Western blots are indicated. (c) Western blot analysis of cell lysate (CL) and 
supernatant (SN) of non-targeting control, caspase-1 and ASC sgRNA CRISPR/Cas9-targetd 
HPKs or wild-type cells maintained on feeder cells. (d) ELISA for IL-1β quantification in 
supernatants of untreated and UVB-irradiated control, caspase-1 and ASC sgRNA 
CRISPR/Cas9-targetd HPKs and wild-type keratinocytes. (e) Western blot analysis using cell 
lysate of control, caspase-1 and ASC sgRNA CRISPR/Cas9-targetd HPKs and wild-type 
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HPKs. Cells were harvested at the exponential growth phase (exp), when reaching confluency 
(conf), both in keratinocyte medium, or after the indicated days in keratinocyte differentiation 
medium (DM). sgRNA targeted genes and antibodies used for Western blots are indicated. 
Data are expressed as the mean ± SEM of three independent experiments using two-way 
analysis of variance (ANOVA) with Dunnett’s multiple-comparison test (d) or are 
representative of three independent experiments (c). 
 
Figure 3. NLRP1, but not NLRP3, has a key role in sensing UVB radiation and nigericin 
in HPKs. 
Non-targeting control, ASC, NLRP1 (2 sequences) and NLRP3 (2 sequences) CRISPR/Cas9-
targeted HPKs were either primed overnight with IFNγ (20 ng/ml) or left untreated. Western 
blot analysis using cell lysate (CL) of mock-treated cells (a). Supernatant (SN) of UVB-
irradiated and nigericin-treated cells was analyzed by Western blot for secretion of the 
indicated proteins (b). Quantification of band signal intensity of secreted mature IL-1β and 
IL-18 normalized to the corresponding untreated samples from three independent experiments 
(c and Supplementary Figure S4). Supernatant (SN) of UVB-irradiated and nigericin-treated 
cells was analyzed by ELISA for IL-1β secretion levels (d) or for LDH release (e). sgRNA 
targeted genes and antibodies used for Western blots are indicated. Data are expressed as the 
mean ± SEM of four (d-e) or three (c) independent experiments using one-way analysis of 
variance (ANOVA) with Dunnett’s multiple-comparison test (d-e) or are representative of 
three independent experiments (a). 
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